Re: Sigrid V. Carlsson, Rebecka Arnsrud Godtman, Carl-Gustav Pihl, et al. Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial. Eur Urol. 2023;83:103-9

被引：0
|
作者：
Kim, Ki Min [1 ]
Kim, Jae Heon [1 ,3 ]
Chung, Benjamin I. [2 ]
机构：
[1] Soonchunhyang Univ, Soonchunhyang Univ Hosp, Dept Urol, Coll Med, Seoul, South Korea
[2] Stanford Univ, Dept Urol, Med Ctr, Stanford, CA USA
[3] Soonchunhyang Univ, Soonchunhyang Univ Seoul Hosp, Dept Urol, Med Coll, 59 Daesagwan-ro, Seoul 04401, South Korea
来源：
EUROPEAN UROLOGY | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2022.12.037
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E137 / E138
页数：2
相关论文
共 5 条
  • [1] Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial
    Carlsson, Sigrid, V
    Godtman, Rebecka Arnsrud
    Pihl, Carl-Gustav
    Vickers, Andrew
    Lilja, Hans
    Hugosson, Jonas
    Mansson, Marianne
    EUROPEAN UROLOGY, 2023, 83 (02) : 103 - 109
  • [2] Corrigendum to "Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial'' (vol 83, pg 103, 2023)
    Carlsson, Sigrid, V
    Godtman, Rebecka Arnsrud
    Pihl, Carl-Gustav
    Vickers, Andrew
    Lilja, Hans
    Hugosson, Jonas
    Mansson, Marianne
    EUROPEAN UROLOGY, 2023, 83 (03) : E88 - E88
  • [3] Re: Young Age on Starting Prostate-specific Antigen Testing Is Associated With a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial Editorial Comment
    Taneja, Samir S.
    Carlsson, S., V
    Arnsrud, Godtman R.
    Pihl, C. G.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 219 - 220
  • [4] Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7
    Penney, Kathryn L.
    Loda, Massimo
    Stampfer, Meir J.
    EUROPEAN UROLOGY, 2019, 75 (03) : E54 - E55
  • [5] Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7
    Vickers, Andrew J.
    Lilja, Hans
    Assel, Melissa
    EUROPEAN UROLOGY, 2019, 75 (03) : E56 - E56
1